Effects of Dual Inhibition at Dopamine Transporter and σ Receptors in the Discriminative-Stimulus Effects of Cocaine in Male Rats.

IF 3.1 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Takato Hiranita, Su-Min Li, Jonathan L Katz
{"title":"Effects of Dual Inhibition at Dopamine Transporter and σ Receptors in the Discriminative-Stimulus Effects of Cocaine in Male Rats.","authors":"Takato Hiranita, Su-Min Li, Jonathan L Katz","doi":"10.1124/jpet.124.002239","DOIUrl":null,"url":null,"abstract":"<p><p>Previous studies demonstrated that sigma receptor (<i>σ</i>R) antagonists alone fail to alter cocaine self-administration despite blocking various other effects of cocaine. However, <i>σ</i>R antagonists when combined with dopamine transporter (DAT) inhibitors substantially decrease cocaine self-administration. To better understand the effects of this combination, the present study examined the effects of <i>σ</i>R antagonist and DAT inhibitor combinations in male rats discriminating cocaine (10 mg/kg, i.p.) from saline injections. The DAT inhibitors alone [(-)-2-β-carbomethoxy-3-β-(4-fluorophenyl)tropane 1,5-naphthalenedisulfonate monohydrate (WIN 35,428) and methylphenidate] at low (0.1-mg/kg) doses that were minimally active failed to shift the dose-effect function for discriminative-stimulus effects of cocaine to the left more than 2-fold. At 0.32 mg/kg the DAT inhibitors alone shifted the cocaine dose-effect function leftward 24- or 6.6-fold, respectively. The <i>σ</i>R antagonists (BD1008, BD1047, and BD1063) failed to fully substitute for cocaine, although BD1008 and BD1047 substituted partially. At 10 mg/kg, BD1008, BD1047, or BD1063 alone shifted the cocaine dose-effect function leftward less than 6.0-fold. In combination with 0.1 mg/kg WIN 35,428, the 10 mg/kg doses of <i>σ</i>R antagonists shifted the cocaine dose-effect function from 12.3- to 36.7-fold leftward, and with 0.32 mg/kg WIN 35,428 from 14.3- to 440-fold leftward. In combination with 0.1 mg/kg methylphenidate, those <i>σ</i>R antagonist doses shifted the cocaine dose-effect function from 5.5- to 55.0-fold leftward, and with 0.32 mg/kg methylphenidate from 10.5- to 48.1-fold leftward. The present results suggest that dual DAT/<i>σ</i>R inhibition produces agonist-like subjective effects that may promote decreases in self-administration obtained in previous studies. SIGNIFICANCE STATEMENT: There is currently no approved medication for treating stimulant abuse, although dopamine uptake inhibitors in combination with sigma receptor (<i>σ</i>R) antagonists decrease cocaine self-administration in laboratory animals. The present study assessed how this combination alters the discriminative-stimulus effects of cocaine in male rats. Results suggest that concurrent dopamine uptake inhibition and <i>σ</i>R antagonism together may promote decreases in self-administration, possibly by mimicking the subjective effects extant when subjects cease continued cocaine self-administration.</p>","PeriodicalId":16798,"journal":{"name":"Journal of Pharmacology and Experimental Therapeutics","volume":" ","pages":"308-316"},"PeriodicalIF":3.1000,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11493437/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacology and Experimental Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1124/jpet.124.002239","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Previous studies demonstrated that sigma receptor (σR) antagonists alone fail to alter cocaine self-administration despite blocking various other effects of cocaine. However, σR antagonists when combined with dopamine transporter (DAT) inhibitors substantially decrease cocaine self-administration. To better understand the effects of this combination, the present study examined the effects of σR antagonist and DAT inhibitor combinations in male rats discriminating cocaine (10 mg/kg, i.p.) from saline injections. The DAT inhibitors alone [(-)-2-β-carbomethoxy-3-β-(4-fluorophenyl)tropane 1,5-naphthalenedisulfonate monohydrate (WIN 35,428) and methylphenidate] at low (0.1-mg/kg) doses that were minimally active failed to shift the dose-effect function for discriminative-stimulus effects of cocaine to the left more than 2-fold. At 0.32 mg/kg the DAT inhibitors alone shifted the cocaine dose-effect function leftward 24- or 6.6-fold, respectively. The σR antagonists (BD1008, BD1047, and BD1063) failed to fully substitute for cocaine, although BD1008 and BD1047 substituted partially. At 10 mg/kg, BD1008, BD1047, or BD1063 alone shifted the cocaine dose-effect function leftward less than 6.0-fold. In combination with 0.1 mg/kg WIN 35,428, the 10 mg/kg doses of σR antagonists shifted the cocaine dose-effect function from 12.3- to 36.7-fold leftward, and with 0.32 mg/kg WIN 35,428 from 14.3- to 440-fold leftward. In combination with 0.1 mg/kg methylphenidate, those σR antagonist doses shifted the cocaine dose-effect function from 5.5- to 55.0-fold leftward, and with 0.32 mg/kg methylphenidate from 10.5- to 48.1-fold leftward. The present results suggest that dual DAT/σR inhibition produces agonist-like subjective effects that may promote decreases in self-administration obtained in previous studies. SIGNIFICANCE STATEMENT: There is currently no approved medication for treating stimulant abuse, although dopamine uptake inhibitors in combination with sigma receptor (σR) antagonists decrease cocaine self-administration in laboratory animals. The present study assessed how this combination alters the discriminative-stimulus effects of cocaine in male rats. Results suggest that concurrent dopamine uptake inhibition and σR antagonism together may promote decreases in self-administration, possibly by mimicking the subjective effects extant when subjects cease continued cocaine self-administration.

多巴胺转运体和σ受体双重抑制对雄性大鼠可卡因辨别刺激效应的影响
以前的研究表明,σR受体(σR)拮抗剂虽然能阻断可卡因的其他各种作用,但单独使用却不能改变可卡因的自我给药性。然而,当σR拮抗剂与多巴胺转运体(DAT)抑制剂结合使用时,可卡因自我药瘾会大幅降低。为了更好地了解这种组合的效果,本研究考察了σR拮抗剂和DAT抑制剂组合对雄性大鼠辨别可卡因(10毫克/千克,静脉注射)和生理盐水注射的效果。单用低剂量(0.1 毫克/千克)DAT 抑制剂(WIN 35,428 和哌醋甲酯)的活性极低,但可卡因分辨刺激效应的剂量-效应函数向左移动的幅度不超过两倍。当剂量为 0.32 毫克/千克时,DAT 抑制剂单独使用会使可卡因剂量效应函数分别向左移动 24 倍或 6.6 倍。σR拮抗剂(BD1008、BD1047和BD1063)未能完全替代可卡因,但BD1008和BD1047可部分替代可卡因。在 10 毫克/千克的剂量下,BD1008、BD1047 或 BD1063 单独使用时,可卡因剂量效应函数向左移动不到 6.0 倍。与 0.1 毫克/千克 WIN 35,428 联合使用时,10 毫克/千克剂量的 σR 拮抗剂可使可卡因剂量效应函数向左移动 12.3 至 36.7 倍,与 0.32 毫克/千克 WIN 35,428 联合使用时,可使可卡因剂量效应函数向左移动 14.3 至 440 倍。与 0.1 毫克/千克哌醋甲酯结合使用时,这些 σR 拮抗剂剂量可使可卡因剂量效应函数从 5.5 左移至 55.0 倍,与 0.32 毫克/千克哌醋甲酯结合使用时则从 10.5 左移至 48.1 倍。本研究结果表明,DAT/σR双重抑制可产生类似于激动剂的主观效应,这可能会促进之前研究中获得的自我给药下降。意义声明 虽然多巴胺摄取抑制剂与σR受体(σR)拮抗剂联合使用会降低实验动物的可卡因自我药瘾,但目前还没有获准用于治疗兴奋剂滥用的药物。本研究评估了这种组合如何改变雄性大鼠的可卡因分辨刺激效应。结果表明,同时使用多巴胺摄取抑制剂和σR拮抗剂可能会通过模拟受试者停止持续自我吸食可卡因时的主观效应,从而促进自我吸食量的减少。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.90
自引率
0.00%
发文量
115
审稿时长
1 months
期刊介绍: A leading research journal in the field of pharmacology published since 1909, JPET provides broad coverage of all aspects of the interactions of chemicals with biological systems, including autonomic, behavioral, cardiovascular, cellular, clinical, developmental, gastrointestinal, immuno-, neuro-, pulmonary, and renal pharmacology, as well as analgesics, drug abuse, metabolism and disposition, chemotherapy, and toxicology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信